In 2025, Haemonetics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Haemonetics has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Scope 1 | 3,101a | 3,655a | 3,842a | |
Total Scope 2 | ||||
Market-Based | 18,376a | 19,124a | 17,162a | |
Location-Based | 18,195a | 19,147a | 17,245a | |
Total Scope 3 | N/A | N/A | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 2.2788a | 2.7921a | 3.2875a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, the total operational greenhouse gas (GHG) emissions of Haemonetics amounted to 21,296 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Haemonetics decreased by 6.6%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2025, the total Scope 1 emissions of Haemonetics were 3,101 metric tons of CO₂ equivalent (tCO₂e).a
Since 2019, Haemonetics's Scope 1 emissions have decreased by 27.46%, reflecting a declining long-term trend in Scope 1 emissions over time.a
Compared to the previous year (2024), Haemonetics's Scope 1 emissions decreased by 15.16%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2025, Haemonetics reported Scope 2 greenhouse gas (GHG) emissions of 18,376 tCO₂e using the market-based method and 18,195 tCO₂e using the location-based method.a
Since 2019, Haemonetics's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 16.86%, reflecting a declining long-term trend in Scope 2 emissions over time.a
Compared to the previous year (2024), Haemonetics's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Haemonetics's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2025, Haemonetics reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2025, Haemonetics reported Scope 1 greenhouse gas (GHG) emissions of 3,101 tCO₂e and total revenues of USD 1,361 millions. This translates into an emissions intensity of 2.28 tCO₂e per millions USD.a
In 2025, Haemonetics reported a Scope 1 emissions intensity of 2.28 tCO₂e per millions USD. Compared to the peer group median of 2.94, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2025, Haemonetics ranked 11 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
Haemonetics is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a